Angstrom Bio

Angstrom Bio is a private Austin-based biotechnology and diagnostics company focused on applying machine learning, novel nucleotide chemistry, and nanopore/amplicon sequencing to human health. Its principal disclosed product is AMPD, an NGS-based molecular diagnostics platform designed for high-throughput, low-cost, high-frequency testing of COVID-19 and other respiratory pathogens. The company has also described computational capabilities for antibody optimization and broader applications in the study, diagnosis, and treatment of disease. Publicly available information suggests Angstrom Bio remains a small, venture-backed company with an emphasis on platform-enabled molecular diagnostics rather than a traditional therapeutic drug pipeline.